Simplex Trading’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
69,000
+5,900
+9% +$94.2K ﹤0.01% 2490
2025
Q4
$486K Buy
63,100
+16,100
+34% +$127K ﹤0.01% 3330
2025
Q3
$346K Buy
47,000
+19,700
+72% +$101K ﹤0.01% 4282
2025
Q2
$109K Sell
27,300
-12,100
-31% -$44K ﹤0.01% 5148
2025
Q1
$125K Sell
39,400
-12,600
-24% -$59.3K ﹤0.01% 4824
2024
Q4
$278K Buy
52,000
+15,700
+43% +$117K ﹤0.01% 4149
2024
Q3
$191K Buy
36,300
+24,400
+205% +$87.6K ﹤0.01% 4559
2024
Q2
$21K Buy
11,900
+3,500
+42% +$6.52K ﹤0.01% 6839
2024
Q1
$14K Sell
8,400
-11,200
-57% -$23.4K ﹤0.01% 7366
2023
Q4
$34K Buy
19,600
+8,600
+78% +$12.6K ﹤0.01% 6449
2023
Q3
$16K Sell
11,000
-10,600
-49% -$22.4K ﹤0.01% 6803
2023
Q2
$49K Buy
+21,600
New +$44.9K ﹤0.01% 5868
2023
Q1
Sell
-11,000
Closed -$9K 9170
2022
Q4
$9K Buy
11,000
+700
+7% +$619 ﹤0.01% 7610
2022
Q3
$8K Buy
+10,300
New +$9.83K ﹤0.01% 8389
2022
Q2
Sell
-3,700
Closed -$6K 10101
2022
Q1
$6K Sell
3,700
-33,700
-90% -$61.7K ﹤0.01% 9268
2021
Q4
$90K Buy
37,400
+31,300
+513% +$121K ﹤0.01% 6425
2021
Q3
$16K Hold
6,100
﹤0.01% 8604
2021
Q2
$16K Buy
6,100
+6,083
+35,782% +$16.7K ﹤0.01% 8760
2021
Q1
$5K Sell
17
-369
-96% -$1.33K ﹤0.01% 8190
2020
Q4
$137K Buy
386
+362
+1,508% +$1.46K ﹤0.01% 5091
2020
Q3
$9K Buy
+24
New +$96 ﹤0.01% 6833
2020
Q1
Sell
-30
Closed -$16K 7682
2019
Q4
$16K Buy
+30
New +$105 ﹤0.01% 6097

Other funds holding CRVS